The Impact of Trunk Control and Balance on Functional Skills in Ambulatory Children With Duchenne Muscular Dystrophy

Gülsena Utku Umut1, Zeynep Hoşbay1, Edibe Pempegül Yıldız2

  • 1Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Biruni University, Istanbul, Turkey.

Insights

Trunk control and balance significantly impact functional abilities like self-care and mobility in children with Duchenne Muscular Dystrophy (DMD). Improving these skills may enhance daily activities for ambulatory boys with DMD.

Area of Science:

  • Pediatric Physical Therapy
  • Neuromuscular Disorders
  • Rehabilitation Medicine

Background:

  • Children with Duchenne Muscular Dystrophy (DMD) often exhibit impaired trunk control and balance, affecting functional capabilities.
  • These impairments can negatively influence motor skills and independence in daily activities.

Purpose of the Study:

  • To investigate the relationship between trunk control, balance, and functional skills in ambulatory children diagnosed with DMD.
  • To identify specific aspects of trunk control and balance that correlate with functional performance.

Main Methods:

  • Thirty-two ambulatory boys with DMD (ages 5-12) participated.
  • Assessments included the Trunk Control Measurement Scale (TCMS), Pediatric Functional Reach Test (PFRT), Timed-Up-and-Go Test (TUG), and Pediatric Evaluation of Disability Inventory (PEDI).

Main Results:

  • PEDI self-care scores correlated with TCMS selective movement control and PFRT.
  • PEDI mobility scores showed significant correlations with TCMS static sitting balance, selective movement control, PFRT, and TUG.
  • No significant correlations were found between PEDI social function scores and trunk control or balance measures.

Conclusions:

  • Trunk control and balance are crucial for functional performance in ambulatory children with DMD.
  • Improvements in trunk control and balance are likely to enhance self-care and mobility domains.
  • These findings underscore the importance of targeted interventions focusing on trunk stability and balance for this population.
Abstract

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.7K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417